comparemela.com

Page 13 - Cancer Genome News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Astronomy meets pathology to identify predictive biomarkers for cancer immunotherapy

 E-Mail IMAGE: The AstroPath platform allows for the assessment of the level of expression of a given marker on individual cells, while maintaining information on their spatial location. Shown here is. view more  Credit: Seyoun Park, Ph.D. Pairing sky-mapping algorithms with advanced immunofluorescence imaging of cancer biopsies, researchers at The Mark Foundation Center for Advanced Genomics and Imaging at Johns Hopkins University and the Bloomberg~Kimmel Institute for Cancer Immunotherapy developed a robust platform to guide immunotherapy by predicting which cancers will respond to specific therapies targeting the immune system. A new platform, called AstroPath, melds astronomic image analysis and mapping with pathology specimens to analyze microscopic images of tumors.

Eisai and National Cancer Center Commence Joint Research and Development Project

Eisai and National Cancer Center Commence Joint Research and Development Project Using PDX With High Predictability of Clinical Outcomes, and Cancer Genome Data TOKYO, May 14, 2021 - (JCN Newswire) - Eisai Co., Ltd. and the National Cancer Center Japan announced today that both parties have entered into a joint research and development (R&D) agreement concerning Basic research on the drug discovery and development to accelerate development of anticancer drugs in treatment of patients with rare cancers and refractory cancers , and that research activities have commenced. This R&D project is to be carried out with funding under the program Cyclic Innovation for Clinical Empowerment (CiCLE) established by the Japan Agency for Medical Research and Development (AMED).

35 years later, research shows the Chernobyl silver lining

Cancer is caused by mutations in human DNA. Some lines of the genetic code are deleted or confused and this change allows the cells to proliferate and

Tufts Announces Honorary Degree Recipients for Class of 2021

Tufts University honorary degree recipients for the Class of 2021 will include a leader in New England’s COVID-19 response, an innovative medical researcher, a food entrepreneur renowned for his humanitarian work, a linguist dedicated to preserving America’s indigenous languages, and a Tufts alumna serving in the highest ranks of the U.S. Army. The group joins lawyer, author, and civil rights advocate Bryan Stevenson in being recognized with honorary degrees for their work. Stevenson was previously announced as the commencement speaker for the Class of 2021 and will receive an honorary Doctor of Laws degree. All degrees will be conferred during the all-university ceremony, to be held virtually on the morning of May 23.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.